Tissue Engineering & Stem Cell Technology Report 2007

The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the commercial opportunities within Tissue Engineering & Stem Cell Technology. Tissue engineering, the manufacture of complete tissues outside of the body ready for future transplant use, is already with us, including several types of replacement skin and a cartilage substitute. The estimated market for future tissue engineered products including the regeneration of bone, cartilage, and other connective structural treatments is worth approximately $5 billion worldwide. The report 'Tissue Engineering and Stem Cell Technology Report 2007' will analyse these two highly lucrative markets for you and will include: An in-depth explanation of the physiology behind stem cell technology A listing of over 100 companies involved and a survey of the principle companies in stem cell development An examination of the products in development & the likely clinical areas for future treatments An in-depth assessment of the future markets delivered to you today A thorough examination of the ethical and regulatory aspects behind stem cell research A detailed analysis of the financial position of the market as it stands and future projections of growth Methodology The information contained in this report is from primary industry sources. This includes one-on-one interviews with companies, with governmental bodies and academic institutions. Analysis has also been drawn from company reports, whether annual financial returns or white papers. The author of this report has dealt with over 50+ companies and industry contacts to assist on the production of this report. Targeted directly at you this report is designed to be used primarily by executives, investors, venture capitalists, and business development managers and analysts involved in the pharmaceutical or biotechnology areas that may have an interest in stem cell technology. This market has grown rapidly since the isolation of embryonic stem cells in 1998. With the technologies that impact stem cells catching up to the rate of research, now is your last chance to corner a section of this market. It is the multifaceted role of stem cells in a whole wide range of diseases that accounts for this huge potential. The diseases that stem cell technology may offer treatments for includes: Parkinson's Disease Diabetes Chronic Heart Disease Kidney Disease Liver Failure Cancer Spinal Cord Injury Multiple Sclerosis Alzheimer's Disease Gene Therapy Why you must buy this report: The pharmaceutical industry has been seeking the next blockbuster drug, yet it appears as though these might not be as profligate as they have been in the past. However, the tissue engineering & stem cell treatment hold promise. This report analyses the current situation in the market and assesses the potential of work that are currently in the pipeline. You and your company should be part of this market, and you could be by placing your order immediately. Unique benefits to you when you order this report Immediate access through our exclusive Reading Room You can access your report whichever country you are in without using hard drive space Primary research throughout. You will not find this information anywhere else Report stored in your reading room for ever Full searchable report when you buy the company or corporate editions Copies can be printed off for offline reading Packed with charts, analysis, figures, graphs and tables Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Additional Information


Aarstrom Biosciences Inc.
Acorda Therapeutics
Advanced BioHealing, Inc.
Advanced Cell Technology Inc.
Aldagen, Inc.
American Society of Plastic Surgeons
Amersham
Amgen
Angel BioTechnology
Ansary Center for Stem Cell Therapeutics
Arthritis Research Campaign, UK
AstraZeneca
Athersys
Axordia
Bart's and The London NHS Trust, UK
BioE
Bioheart, Inc.
Biotechnology and Biological Sciences Research Council, UK
BrainStorm Cell Therapeutics
BresaGen
Burnham Institute for Medical Research
The California Family Bioethics Council
California Institute for Regenerative Medicine
Cellartis
CellCura
Cellerant
Cellular Dynamics International
The Cellulite Clinic Center for Stem Cell and Regenerative Medicine, Ohio
Cordlife
Cythera/ Novocell
Cytori Therapeutics Department of Health and Human Services, US
Epistem
ES Cell International (ESI)
European Patent Office
Fisher
Food and Drug Administration, US
Gamida
Genentech
Genzyme
Geron
GlobalStem Inc
Human Fertilisation and Embryology Authority, UK
Illinois Regenerative Medicine Institute
Institute for Regenerative Medicine
Intercytex
Invitrogen
The Joan and Sanford I Weill Medical Centre
Johns Hopkins University
Johnson and Johnson
Juvenile Diabetes Research Foundation
King's College, London
Maryland Technology Development Corporation
Mediatech Inc
Medical Research Council, UK
Medra Clinic
Memorial Sloan-Kettering Cancer Centre
Merck
Mesoblast Limited
Nabi Medspa
The National Academies, US
The National Institutes of Health, US
National Health Service
National Science Foundation
National Tax Limitation Committee
Neuronova
New Jersey Stem Cell Institute
Novartis AG
Novathera
Novocell
Odontis
Organogenesis
Osiris
Pluristem
RegenTec
Reinnervate
Reliance Life Sciences
ReNeuron
Renovo
RhinoCyte, Inc.
Rockefeller University
Roslin Institute
Royal College of Obstetrics and Gynaecologists, UK Schering AG Sigma-Aldrich Smith and Nephew The Starr Foundation Stem Cells Inc.
Stem Cell Innovations
StemCell Technologies Inc.
Stem Cell Therapeutics Corp
Stem Cell Sciences
StemCo Biomedical
Stempeutics
Tengion
TheraVitae
Titan Pharmaceuticals Inc.
Tulane University
UK Stem Cell Bank
United States Patents and Trademark Office
University of Maryland
University of Massachusetts
University of Newcastle
University of San Francisco, California
University of Texas Health Centre
University of Wisconsin
Vesta Therapeutics Inc.
Viacell
Vistagen Therapeutics Inc.
Wellcome Trust, UK
WiCell Research Institute, US
Wisconsin Alumni Research Foundation
Wisconsin State Laboratory of Hygiene
Wolfson Foundation, UK
World Health Organisation